NESARC-III Publications - Final - 8 - 10 - 16
NESARC-III Publications - Final - 8 - 10 - 16
Publications
(updated 8/10/16)
1
(1) Smith SM, Goldstein RB, Grant BF. The association between post-
traumatic stress disorder and lifetime DSM-5 psychiatric disorders among
veterans: data from the National Epidemiologic Survey on Alcohol and
Related Conditions-III (NESARC-III). J Psychiatr Res. 2016;82:16-22.
(2) Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J,
Pickering RB, Ruan WJ, Smith SM, Huang B, Hasin DS, Grant BF.
Nonmedical prescription opioid use and DSM-5 nonmedical prescription
opioid use disorder in the United States. J Clin Psychiatry. 2016;77:772-
780.
(3) Chou SP, Goldstein RB, Smith SM, Huang B, Ruan WJ, Zhang H, Jung J,
Saha TD, Pickering RP, Grant BF. The epidemiology of DSM-5 nicotine
use disorder: results from the National Epidemiologic Survey on Alcohol
and Related Conditions-III. J Clin Psychiatry. 2016 Apr 26. [Epub ahead
of print]
(4) Goldstein RB, Smith SM, Chou SP, Saha TD, Jung J, Zhang H, Pickering
RB, Ruan WJ, Huang B, Grant BF. The epidemiology of DSM-5
posttraumatic stress disorder in the United States: results from the National
Epidemiologic Survey on Alcohol and Related Conditions-III. Soc
Psychiatry Psychiatri Epidemiol. 2016 Apr 22 [Epubl ahead of print]
(5) Goldstein RB, Chou SP, Saha TD, Smith SM, Jung J, Zhang H, Pickering
RB, Ruan WJ, Huang B, Grant BF. The epidemiology of antisocial
behavioral syndromes in adulthood: results from the National
Epidemiologic Survey on Alcohol and Related Conditions-III. J Clin
Psychiatry. 2016 Mar 15 [Epub ahead of print]
(6) Hasin DS, Kerridge BT, Saha TD, Huang B, Pickering R, Smith SM, Jung
J, Zhang H, Grant BF. Prevalence and correlates of DSM-5 cannabis use
disorder, 2012-2013: finding from the National Epidemiologic Survey on
Alcohol and Related Conditions-III. Am J Psychiatry. 2016;173:588-599.
(7) Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H,
Smith SM Pickering RP, Huang B, Hasin DS. Epidemiology of DSM-5
drug use disorder: results from the National Epidemiologic Survey on
Alcohol and Related Conditions-III. JAMA Psychiatry. 2016;73:39-47.
(8) Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung
J, Pickering RP, Ruan WJ, Smith SM, Huang B, Grant BF. Prevalence of
marijuana use disorders in the United States between 2001-2002 and 2012-
2013. JAMA Psychiatry. 2015;72:1235-1242.
(9) Hasin DS, Grant BF. The National Epidemiologic Survey on Alcohol and
Related Conditions (NESARC) Waves 1 and 2: review and summary of
findings. Soc Psychiatry Psychiatr Epidemiol. 2015;50:1609-1640.
2
(10) Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP,
Ruan WJ, Smith SM, Huang B, Hasin DS. The epidemiology of DSM-5 alcohol
use disorder: results from the National Epidemiologic Survey on Alcohol and
Related Conditions – III. JAMA Psychiatry. 2015;72:757-766
(12) Grant BF, Goldstein RB, Smith SM, Jung J, Zhang H, Chou SP, Pickering RP,
Ruan WJ, Huang B, Saha TD, Aivadyan C, Greenstein E, Hasin DS. The Alcohol
Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5):
reliability of substance use and psychiatric disorder modules in a general
population sample. Drug Alcohol Depend. 2015;148:27-33
(13) Dawson DA, Goldstein RB, Saha TD, Grant BF. Changes in alcohol
consumption: United States, 2001-2 to 2012-13. Drug Alcohol Depend. 2015;
148:56-61.
(15) Goldstein RB, Chou SP, Smith SM, Jung J, Zhang H, Saha TD, Pickering RP,
Ruan WJ, Huang B, Grant BF. Nosologic comparisons of DSM-IV and DSM-5
alcohol and drug use disorders: results from the National Epidemiologic Survey
on Alcohol and Related Conditions-III. J Stud Alc Drugs. 2015;76:378-388.